APO Research
Talk to an analyst

APO RESEARCH · REPORT

Montelukast Intermediate

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Montelukast Intermediate Industry Growth and Trends Forecast to 2032

20 December 202575 pages

Choose your research edition.

Industry ResearchMontelukast Intermediate Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Montelukast Intermediate Industry Growth and Trends Forecast to 203275 pages · $3,450 USDMarket StructureGlobal Montelukast Intermediate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Montelukast Intermediate Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Montelukast Intermediate Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Montelukast Intermediate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Montelukast Intermediate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Montelukast Intermediate is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Montelukast Intermediate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Montelukast Intermediate include VIVAN Life Sciences, P.G. Shah & Co., Ortin Laboratories and Manus Aktteva Biopharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Montelukast Intermediate market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Montelukast Intermediate market size, estimates, and forecasts are presented in terms of sales volume (tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Montelukast Intermediate market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Montelukast Intermediate.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Montelukast Intermediate market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Montelukast Intermediate Market by Company

VIVAN Life Sciences

P.G. Shah & Co.

Ortin Laboratories

Manus Aktteva Biopharma

Montelukast Intermediate Segment by Type

GMP

Non-GMP

Montelukast Intermediate Segment by Application

Bronchospasm

Urticaria

Asthma

Allergic Rhinitis

Montelukast Intermediate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Montelukast Intermediate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Montelukast Intermediate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Montelukast Intermediate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Montelukast Intermediate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Montelukast Intermediate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of GMP Table 2. Major Company of Non-GMP Table 3. Global Montelukast Intermediate Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Montelukast Intermediate Sales by Type (2021-2026) & (tons) Table 5. Global Montelukast Intermediate Sales Market Share in Volume by Type (2021-2026) Table 6. Global Montelukast Intermediate Sales by Type (2021-2026) & (US$ Million) Table 7. Global Montelukast Intermediate Sales Market Share in Value by Type (2021-2026) Table 8. Global Montelukast Intermediate Price by Type (2021-2026) & (US$/ton) Table 9. Global Montelukast Intermediate Sales by Type (2027-2032) & (tons) Table 10. Global Montelukast Intermediate Sales Market Share in Volume by Type (2027-2032) Table 11. Global Montelukast Intermediate Sales by Type (2027-2032) & (US$ Million) Table 12. Global Montelukast Intermediate Sales Market Share in Value by Type (2027-2032) Table 13. Global Montelukast Intermediate Price by Type (2027-2032) & (US$/ton) Table 14. North America Montelukast Intermediate Sales by Type (2021-2026) & (tons) Table 15. North America Montelukast Intermediate Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Montelukast Intermediate Sales by Type (2021-2026) & (tons) Table 17. Europe Montelukast Intermediate Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Montelukast Intermediate Sales by Type (2021-2026) & (tons) Table 19. Asia-Pacific Montelukast Intermediate Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Montelukast Intermediate Sales by Type (2021-2026) & (tons) Table 21. Latin America Montelukast Intermediate Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Montelukast Intermediate Sales by Type (2021-2026) & (tons) Table 23. Middle East and Africa Montelukast Intermediate Sales by Type (2021-2026) & (US$ Million) Table 24. Montelukast Intermediate Industry Trends Table 25. Montelukast Intermediate Industry Drivers Table 26. Montelukast Intermediate Industry Opportunities and Challenges Table 27. Montelukast Intermediate Industry Restraints Table 28. Global Montelukast Intermediate Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Montelukast Intermediate Revenue Market Share by Company (2021-2026) Table 30. Global Montelukast Intermediate Sales by Company (2021-2026) & (tons) Table 31. Global Montelukast Intermediate Sales Share by Company (2021-2026) Table 32. Global Montelukast Intermediate Market Price by Company (2021-2026) & (US$/ton) Table 33. Global Montelukast Intermediate Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Montelukast Intermediate Major Company Production Sites and Headquarters Table 35. Global Montelukast Intermediate Company, Product Type & Application Table 36. Global Montelukast Intermediate Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Montelukast Intermediate by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Montelukast Intermediate Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Montelukast Intermediate Sales by Region (2021-2026) & (tons) Table 41. Global Montelukast Intermediate Sales Market Share in Volume by Region (2021-2026) Table 42. Global Montelukast Intermediate Sales by Region (2021-2026) & (US$ Million) Table 43. Global Montelukast Intermediate Sales Market Share in Value by Region (2021-2026) Table 44. Global Montelukast Intermediate Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 45. Global Montelukast Intermediate Sales by Region (2027-2032) & (tons) Table 46. Global Montelukast Intermediate Sales Market Share in Volume by Region (2027-2032) Table 47. Global Montelukast Intermediate Sales by Region (2027-2032) & (US$ Million) Table 48. Global Montelukast Intermediate Sales Market Share in Value by Region (2027-2032) Table 49. Global Montelukast Intermediate Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2027-2032) Table 50. Global Montelukast Intermediate Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Montelukast Intermediate Sales by Application (2021-2026) & (tons) Table 52. Global Montelukast Intermediate Sales Market Share in Volume by Application (2021-2026) Table 53. Global Montelukast Intermediate Sales by Application (2021-2026) & (US$ Million) Table 54. Global Montelukast Intermediate Sales Market Share in Value by Application (2021-2026) Table 55. Global Montelukast Intermediate Price by Application (2021-2026) & (US$/ton) Table 56. Global Montelukast Intermediate Sales by Application (2027-2032) & (tons) Table 57. Global Montelukast Intermediate Sales Market Share in Volume by Application (2027-2032) Table 58. Global Montelukast Intermediate Sales by Application (2027-2032) & (US$ Million) Table 59. Global Montelukast Intermediate Sales Market Share in Value by Application (2027-2032) Table 60. Global Montelukast Intermediate Price by Application (2027-2032) & (US$/ton) Table 61. North America Montelukast Intermediate Sales by Application (2021-2026) & (tons) Table 62. North America Montelukast Intermediate Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Montelukast Intermediate Sales by Application (2021-2026) & (tons) Table 64. Europe Montelukast Intermediate Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Montelukast Intermediate Sales by Application (2021-2026) & (tons) Table 66. Asia-Pacific Montelukast Intermediate Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Montelukast Intermediate Sales by Application (2021-2026) & (tons) Table 68. Latin America Montelukast Intermediate Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Montelukast Intermediate Sales by Application (2021-2026) & (tons) Table 70. Middle East and Africa Montelukast Intermediate Sales by Application (2021-2026) & (US$ Million) Table 71. VIVAN Life Sciences Company Information Table 72. VIVAN Life Sciences Business Overview Table 73. VIVAN Life Sciences Montelukast Intermediate Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 74. VIVAN Life Sciences Montelukast Intermediate Product Portfolio Table 75. VIVAN Life Sciences Recent Development Table 76. P.G. Shah & Co. Company Information Table 77. P.G. Shah & Co. Business Overview Table 78. P.G. Shah & Co. Montelukast Intermediate Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 79. P.G. Shah & Co. Montelukast Intermediate Product Portfolio Table 80. P.G. Shah & Co. Recent Development Table 81. Ortin Laboratories Company Information Table 82. Ortin Laboratories Business Overview Table 83. Ortin Laboratories Montelukast Intermediate Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 84. Ortin Laboratories Montelukast Intermediate Product Portfolio Table 85. Ortin Laboratories Recent Development Table 86. Manus Aktteva Biopharma Company Information Table 87. Manus Aktteva Biopharma Business Overview Table 88. Manus Aktteva Biopharma Montelukast Intermediate Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 89. Manus Aktteva Biopharma Montelukast Intermediate Product Portfolio Table 90. Manus Aktteva Biopharma Recent Development Table 91. North America Montelukast Intermediate Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 92. North America Montelukast Intermediate Sales by Country (2021-2026) & (tons) Table 93. North America Montelukast Intermediate Sales Market Share by Country (2021-2026) Table 94. North America Montelukast Intermediate Sales Forecast by Country (2027-2032) & (tons) Table 95. North America Montelukast Intermediate Sales Market Share Forecast by Country (2027-2032) Table 96. North America Montelukast Intermediate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. North America Montelukast Intermediate Market Size by Country (2021-2026) & (US$ Million) Table 98. North America Montelukast Intermediate Market Share by Country (2021-2026) Table 99. North America Montelukast Intermediate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. North America Montelukast Intermediate Market Share Forecast by Country (2027-2032) Table 101. Europe Montelukast Intermediate Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 102. Europe Montelukast Intermediate Sales by Country (2021-2026) & (tons) Table 103. Europe Montelukast Intermediate Sales Market Share by Country (2021-2026) Table 104. Europe Montelukast Intermediate Sales Forecast by Country (2027-2032) & (tons) Table 105. Europe Montelukast Intermediate Sales Market Share Forecast by Country (2027-2032) Table 106. Europe Montelukast Intermediate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Europe Montelukast Intermediate Market Size by Country (2021-2026) & (US$ Million) Table 108. Europe Montelukast Intermediate Market Share by Country (2021-2026) Table 109. Europe Montelukast Intermediate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Europe Montelukast Intermediate Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Montelukast Intermediate Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Montelukast Intermediate Sales by Country (2021-2026) & (tons) Table 113. Asia-Pacific Montelukast Intermediate Sales Market Share by Country (2021-2026) Table 114. Asia-Pacific Montelukast Intermediate Sales Forecast by Country (2027-2032) & (tons) Table 115. Asia-Pacific Montelukast Intermediate Sales Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Montelukast Intermediate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Montelukast Intermediate Market Size by Country (2021-2026) & (US$ Million) Table 118. Asia-Pacific Montelukast Intermediate Market Share by Country (2021-2026) Table 119. Asia-Pacific Montelukast Intermediate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Asia-Pacific Montelukast Intermediate Market Share Forecast by Country (2027-2032) Table 121. Latin America Montelukast Intermediate Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 122. Latin America Montelukast Intermediate Sales by Country (2021-2026) & (tons) Table 123. Latin America Montelukast Intermediate Sales Market Share by Country (2021-2026) Table 124. Latin America Montelukast Intermediate Sales Forecast by Country (2027-2032) & (tons) Table 125. Latin America Montelukast Intermediate Sales Market Share Forecast by Country (2027-2032) Table 126. Latin America Montelukast Intermediate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Latin America Montelukast Intermediate Market Size by Country (2021-2026) & (US$ Million) Table 128. Latin America Montelukast Intermediate Market Share by Country (2021-2026) Table 129. Latin America Montelukast Intermediate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Latin America Montelukast Intermediate Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Montelukast Intermediate Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Montelukast Intermediate Sales by Country (2021-2026) & (tons) Table 133. Middle East and Africa Montelukast Intermediate Sales Market Share by Country (2021-2026) Table 134. Middle East and Africa Montelukast Intermediate Sales Forecast by Country (2027-2032) & (tons) Table 135. Middle East and Africa Montelukast Intermediate Sales Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Montelukast Intermediate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Montelukast Intermediate Market Size by Country (2021-2026) & (US$ Million) Table 138. Middle East and Africa Montelukast Intermediate Market Share by Country (2021-2026) Table 139. Middle East and Africa Montelukast Intermediate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Middle East and Africa Montelukast Intermediate Market Share Forecast by Country (2027-2032) Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Montelukast Intermediate Distributors List Table 144. Montelukast Intermediate Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Montelukast Intermediate Image Figure 2. Global Montelukast Intermediate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Montelukast Intermediate Market Size (2021-2032) & (US$ Million) Figure 4. Global Montelukast Intermediate Sales (2021-2032) & (tons) Figure 5. GMP Image Figure 6. Global GMP Sales YoY Growth (2021-2032) & (tons) Figure 7. Non-GMP Image Figure 8. Global Non-GMP Sales YoY Growth (2021-2032) & (tons) Figure 9. Global Montelukast Intermediate Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Montelukast Intermediate Market Share by Type 2025 VS 2032 Figure 11. North America Montelukast Intermediate Sales Market Share in Volume by Type in 2025 Figure 12. North America Montelukast Intermediate Sales Market Share in Value by Type in 2025 Figure 13. Europe Montelukast Intermediate Sales Market Share in Volume by Type in 2025 Figure 14. Europe Montelukast Intermediate Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Montelukast Intermediate Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Montelukast Intermediate Sales Market Share in Value by Type in 2025 Figure 17. Latin America Montelukast Intermediate Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Montelukast Intermediate Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Montelukast Intermediate Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Montelukast Intermediate Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Montelukast Intermediate Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Bronchospasm Image Figure 24. Global Bronchospasm Sales YoY Growth (2021-2032) & (tons) Figure 25. Urticaria Image Figure 26. Global Urticaria Sales YoY Growth (2021-2032) & (tons) Figure 27. Asthma Image Figure 28. Global Asthma Sales YoY Growth (2021-2032) & (tons) Figure 29. Allergic Rhinitis Image Figure 30. Global Allergic Rhinitis Sales YoY Growth (2021-2032) & (tons) Figure 31. Global Montelukast Intermediate Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Montelukast Intermediate Market Share by Application 2025 VS 2032 Figure 33. North America Montelukast Intermediate Sales Market Share in Volume by Application in 2025 Figure 34. North America Montelukast Intermediate Sales Market Share in Value by Application in 2025 Figure 35. Europe Montelukast Intermediate Sales Market Share in Volume by Application in 2025 Figure 36. Europe Montelukast Intermediate Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Montelukast Intermediate Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Montelukast Intermediate Sales Market Share in Value by Application in 2025 Figure 39. Latin America Montelukast Intermediate Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Montelukast Intermediate Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Montelukast Intermediate Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Montelukast Intermediate Sales Market Share in Value by Application in 2025 Figure 43. North America Montelukast Intermediate Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 44. North America Montelukast Intermediate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Montelukast Intermediate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Montelukast Intermediate Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Montelukast Intermediate Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 48. Europe Montelukast Intermediate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Montelukast Intermediate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Montelukast Intermediate Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Montelukast Intermediate Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 52. Asia-Pacific Montelukast Intermediate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Montelukast Intermediate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Montelukast Intermediate Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Montelukast Intermediate Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 56. Latin America Montelukast Intermediate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Montelukast Intermediate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Montelukast Intermediate Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Montelukast Intermediate Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 60. Middle East and Africa Montelukast Intermediate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Montelukast Intermediate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Montelukast Intermediate Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Montelukast Intermediate Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Montelukast Intermediate Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • GMP
  • Non-GMP
Applications
  • Bronchospasm
  • Urticaria
  • Asthma
  • Allergic Rhinitis
Companies covered
  • VIVAN Life Sciences
  • P.G. Shah & Co.
  • Ortin Laboratories
  • Manus Aktteva Biopharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Montelukast Intermediate Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Montelukast Intermediate Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Montelukast Intermediate Market by Type
  6. 1.3.1 GMP
  7. 1.3.2 Non-GMP
  8. 1.4 Global Montelukast Intermediate Market Size by Type
  9. 1.4.1 Global Montelukast Intermediate Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Montelukast Intermediate Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Montelukast Intermediate Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Montelukast Intermediate Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Montelukast Intermediate Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Montelukast Intermediate Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Montelukast Intermediate Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Montelukast Intermediate Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Montelukast Intermediate Industry Trends
  2. 2.2 Montelukast Intermediate Industry Drivers
  3. 2.3 Montelukast Intermediate Industry Opportunities and Challenges
  4. 2.4 Montelukast Intermediate Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Montelukast Intermediate Revenue (2021-2026)
  2. 3.2 Global Top Players by Montelukast Intermediate Sales (2021-2026)
  3. 3.3 Global Top Players by Montelukast Intermediate Price (2021-2026)
  4. 3.4 Global Montelukast Intermediate Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Montelukast Intermediate Major Company Production Sites & Headquarters
  6. 3.6 Global Montelukast Intermediate Company, Product Type & Application
  7. 3.7 Global Montelukast Intermediate Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Montelukast Intermediate Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Montelukast Intermediate Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Montelukast Intermediate Tier 1, Tier 2, and Tier 3
4 Montelukast Intermediate Regional Status and Outlook
  1. 4.1 Global Montelukast Intermediate Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Montelukast Intermediate Historic Market Size by Region
  3. 4.2.1 Global Montelukast Intermediate Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Montelukast Intermediate Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Montelukast Intermediate Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Montelukast Intermediate Forecasted Market Size by Region
  7. 4.3.1 Global Montelukast Intermediate Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Montelukast Intermediate Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Montelukast Intermediate Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Montelukast Intermediate by Application
  1. 5.1 Montelukast Intermediate Market by Application
  2. 5.1.1 Bronchospasm
  3. 5.1.2 Urticaria
  4. 5.1.3 Asthma
  5. 5.1.4 Allergic Rhinitis
  6. 5.2 Global Montelukast Intermediate Market Size by Application
  7. 5.2.1 Global Montelukast Intermediate Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Montelukast Intermediate Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Montelukast Intermediate Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Montelukast Intermediate Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Montelukast Intermediate Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Montelukast Intermediate Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Montelukast Intermediate Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Montelukast Intermediate Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 VIVAN Life Sciences
  2. 6.1.1 VIVAN Life Sciences Company Information
  3. 6.1.2 VIVAN Life Sciences Business Overview
  4. 6.1.3 VIVAN Life Sciences Montelukast Intermediate Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 VIVAN Life Sciences Montelukast Intermediate Product Portfolio
  6. 6.1.5 VIVAN Life Sciences Recent Developments
  7. 6.2 P.G. Shah & Co.
  8. 6.2.1 P.G. Shah & Co. Company Information
  9. 6.2.2 P.G. Shah & Co. Business Overview
  10. 6.2.3 P.G. Shah & Co. Montelukast Intermediate Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 P.G. Shah & Co. Montelukast Intermediate Product Portfolio
  12. 6.2.5 P.G. Shah & Co. Recent Developments
  13. 6.3 Ortin Laboratories
  14. 6.3.1 Ortin Laboratories Company Information
  15. 6.3.2 Ortin Laboratories Business Overview
  16. 6.3.3 Ortin Laboratories Montelukast Intermediate Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Ortin Laboratories Montelukast Intermediate Product Portfolio
  18. 6.3.5 Ortin Laboratories Recent Developments
  19. 6.4 Manus Aktteva Biopharma
  20. 6.4.1 Manus Aktteva Biopharma Company Information
  21. 6.4.2 Manus Aktteva Biopharma Business Overview
  22. 6.4.3 Manus Aktteva Biopharma Montelukast Intermediate Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Manus Aktteva Biopharma Montelukast Intermediate Product Portfolio
  24. 6.4.5 Manus Aktteva Biopharma Recent Developments
7 North America by Country
  1. 7.1 North America Montelukast Intermediate Sales by Country
  2. 7.1.1 North America Montelukast Intermediate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Montelukast Intermediate Sales by Country (2021-2026)
  4. 7.1.3 North America Montelukast Intermediate Sales Forecast by Country (2027-2032)
  5. 7.2 North America Montelukast Intermediate Market Size by Country
  6. 7.2.1 North America Montelukast Intermediate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Montelukast Intermediate Market Size by Country (2021-2026)
  8. 7.2.3 North America Montelukast Intermediate Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Montelukast Intermediate Sales by Country
  2. 8.1.1 Europe Montelukast Intermediate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Montelukast Intermediate Sales by Country (2021-2026)
  4. 8.1.3 Europe Montelukast Intermediate Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Montelukast Intermediate Market Size by Country
  6. 8.2.1 Europe Montelukast Intermediate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Montelukast Intermediate Market Size by Country (2021-2026)
  8. 8.2.3 Europe Montelukast Intermediate Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Montelukast Intermediate Sales by Country
  2. 9.1.1 Asia-Pacific Montelukast Intermediate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Montelukast Intermediate Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Montelukast Intermediate Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Montelukast Intermediate Market Size by Country
  6. 9.2.1 Asia-Pacific Montelukast Intermediate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Montelukast Intermediate Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Montelukast Intermediate Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Montelukast Intermediate Sales by Country
  2. 10.1.1 South America Montelukast Intermediate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Montelukast Intermediate Sales by Country (2021-2026)
  4. 10.1.3 South America Montelukast Intermediate Sales Forecast by Country (2027-2032)
  5. 10.2 South America Montelukast Intermediate Market Size by Country
  6. 10.2.1 South America Montelukast Intermediate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Montelukast Intermediate Market Size by Country (2021-2026)
  8. 10.2.3 South America Montelukast Intermediate Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Montelukast Intermediate Sales by Country
  2. 11.1.1 Middle East and Africa Montelukast Intermediate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Montelukast Intermediate Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Montelukast Intermediate Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Montelukast Intermediate Market Size by Country
  6. 11.2.1 Middle East and Africa Montelukast Intermediate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Montelukast Intermediate Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Montelukast Intermediate Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Montelukast Intermediate Value Chain Analysis
  2. 12.1.1 Montelukast Intermediate Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Montelukast Intermediate Production Mode & Process
  7. 12.2 Montelukast Intermediate Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Montelukast Intermediate Distributors
  10. 12.2.3 Montelukast Intermediate Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst